Quantification of total and unbound concentrations of lorazepam, oxazepam and temazepam in human plasma by ultrafiltration and LC-MS/MS

Bioanalysis

Volumn 3, Issue 8, 2011, Pages 843-852

  Larsen, Helle S ^a   Chin, Paul K L ^a   Begg, Evan J ^a   Jensen, Berit P ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LORAZEPAM; OXAZEPAM; TEMAZEPAM;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; HUMAN; LIQUID CHROMATOGRAPHY; NORMAL HUMAN; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRAFILTRATION; VALIDATION PROCESS;

ANTI-ANXIETY AGENTS; CALIBRATION; CHROMATOGRAPHY, LIQUID; HEMOFILTRATION; HUMANS; LORAZEPAM; OXAZEPAM; TANDEM MASS SPECTROMETRY; TEMAZEPAM;

EID: 79955381468     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.46     Document Type: Article

References (26)

1. Abishenganaden JA, Aitken ML, Arnold JM et al. Melmon and Morrelli's Clinical Pharmacology (4th Edition). Carruthers SG, Hoffman BB, Melmon KL, Nierenberg DW (Eds). McGraw-Hill, USA (2000).
2. Moffat AC, Osselton MD, Widdop B. Clarke's Analysis of Drugs and Poisons (3rd Edition). Pharmaceutical Press, London, UK (2004).
3. Cudjoe E, Pawliszyn J. A new approach to the application of solid phase extraction disks with LC-MS/MS for the analysis of drugs on a 96-well plate format. J. Pharm. Biomed. Anal. 50(4), 556-562 (2009).
4. Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH. Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spectrom. 39(8), 856-872 (2004). (Pubitemid 39173092)
5. Quintela O, Cruz A, Castro A, Concheiro M, Lopez-Rivadulla M. Liquid chromatography- electrospray ionization mass spectrometry for the determination of nine selected benzodiazepines in human plasma and oral fluid. J. Chrom. B 825(1), 63-71 (2005). (Pubitemid 41262479)
6. Zeng H, Deng Y, Wu J-T. Fast analysis using monolithic columns coupled with high-flow on-line extraction and electrospray mass spectrometric detection for the direct and simultaneous quantitation of multiple components in plasma. J. Chrom. B 788, 331-337 (2003). (Pubitemid 36428536)
7. Zhu H, Luo J. A fast and sensitive liquid chromatographic-tandem mass spectrometric method for assay of lorazepam and application to pharmacokinetic analysis. J. Pharm. Biomed. Anal. 39, 268-274 (2005). (Pubitemid 41112145)
8. Lee X-P, Kumazawa T, Sato J et al. Simple method for the determination of benzodiazepines in human body fluids by high-performance liquid chromatographymass spectrometry. Anal. Chim. Acta 492, 223-231 (2003). (Pubitemid 37101401)
9. Wallace SM, Verbeeck RK. Plasma-protein binding of drugs in the elderly. Clin. Pharmacokinet. 12, 41-72 (1987).
10. Wright JD, Boudinot FD, Ujhelyi MR. Measurement and analysis of unbound drug concentrations. Clin Pharmacokinet. 30(6), 445-462 (1996). (Pubitemid 26175754)
11. US Department of Health and Human Services. Guidance for Industry: bioanalytical method validation. US FDA Center for Drug Evaluation and Research, MD, USA (2001).
12. Smyth WF, McClean S, Ramachandran VN. A study of the electrospray ionization of pharmacologically significant 1,4-benzodiazepines and their subsequent fragmentation using an ion-trap mass spectrometer. Rapid Commun. Mass Spectrom. 14(21), 2061-2069 (2000).
13. Côté C, Bergeron A, Mess J-N, Furtado M, Garofolo F. Matrix effect elimination during LC-MS/MS bioanalytical method development. Bioanalysis 1(7), 1243-1257 (2009).
14. Lee KJ, Mower R, Hollenbeck T et al. Modulation of nonspecific binding in ultrafiltration protein binding studies. Pharm. Res. 20(7), 1015-1021 (2003). (Pubitemid 36774272)
15. Judd RL, Pesce AJ. Free drug concentrations are constant in serial fractions of plasma ultrafiltrate. Clin. Chem. 28(7), 1726-1727 (1982). (Pubitemid 12090706)
16. Whitlam JB, Brown KF. Ultrafiltration in serum protein binding determinations. J. Pharm. Sci. 70(2), 146-150 (1981). (Pubitemid 11131216)
17. Fayet A, Beguin A, de Tejada BM et al. Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction. Ther. Drug Monit. 30(4), 511-522 (2008).
18. Morse DS, Abernethy DR, Greenblatt DJ. Methodologic factors influencing plasma binding of a-1-acid glycoprotein-bound and albumin-bound drugs. Int. J. Clin. Pharmacol. Ther. Toxicol. 23(10), 535-539 (1985). (Pubitemid 15242447)
19. Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm. Res. 24(10), 1962-1973 (2007). (Pubitemid 47389236)
20. Valavani P, Atta-Politou J, Panderi I. Development and validation of a liquid chromatographic/electrospray ionization mass spectrometric method for the quantitation of prazepam and its main metabolites in human plasma. J. Mass Spectrom. 40(4), 516-526 (2005). (Pubitemid 40637876)
21. Divoll M, Greenblatt DJ. Effect of age and sex on lorazepam protein binding. J. Pharm. Pharmacol. 34, 122-123 (1982). (Pubitemid 12154297)
22. Johnson RF, Schenker S, Roberts RK, Desmond PV, Wilkinson GR. Plasma binding of benzodiazepines in humans. J. Pharm. Sci. 68, 1320-1322 (1979). (Pubitemid 10239047)
23. Shull HJ, Wilkinson GR, Johnson R, Schenker S. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann. Intern. Med. 84, 420-425 (1976).
24. Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. Oxazepam kinetics: effects of age and sex. J. Pharmacol. Exp. Ther. 215, 86-91 (1980). (Pubitemid 11072954)
25. Murray TG, Chiang ST, Koepke HH, Walker BR. Renal disease, age, and oxazepam kinetics. Clin. Pharm. Ther. 30, 805-809 (1981). (Pubitemid 12198106)
26. Divoll M, Greenblatt DJ, Harmatz JS, Shader RI. Effect of age and gender on disposition of temazepam. J. Pharm. Sci. 70, 1104-1107 (1981). (Pubitemid 12198374)